Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Whitney

Showing results (441-450 of 572) with videos related to

Pageof 58
Sort By:
PLOS Global Public Health|February 13, 2025
Postmortem point-of care hemoglobin testing is feasible and potentially accurate among children in South AfricaJeanie du Toit, Yuqing Wang, Hanqi Luo, et al.
Vaccine|May 11, 2005
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Kathleen M Neuzil, Cynthia G Whitney, et al.
The New England Journal of Medicine|May 2, 2003
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccineCynthia G Whitney, Monica M Farley, James Hadler, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adultsDaniel R Feikin, Cheryl M Elie, Matthew B Goetz, et al.
BMC Public Health|December 9, 2016
Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introductionShampa Saha, Md Hasan, Lindsay Kim, et al.
Cell Reports|January 18, 2016
T Cell Help Amplifies Innate Signals in CD8(+) DCs for Optimal CD8(+) T Cell PrimingMarie Greyer, Paul G Whitney, Angus T Stock, et al.
Vaccine|October 24, 2001
Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adultsD R Feikin, C M Elie, M B Goetz, et al.
Journal of Clinical Microbiology|July 1, 1997
The role of arbitrarily primed PCR in identifying the source of an outbreak of Legionnaires' diseaseC G Whitney, J Hofmann, J M Pruckler, et al.
Vaccine|March 20, 2025
Impact of 10-valent pneumococcal conjugate vaccine on the epidemiology of otitis media with otorrhea among Bangladeshi childrenHakka Naziat, Md Hafizur Rahman, Rajib C Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003Carolyn M Greene, Moe H Kyaw, Susan M Ray, et al.
Pageof 58

Showing results (441-450 of 572) with videos related to

Sort By:
Pageof 58
PLOS Global Public Health|February 13, 2025
Postmortem point-of care hemoglobin testing is feasible and potentially accurate among children in South AfricaJeanie du Toit, Yuqing Wang, Hanqi Luo, et al.
Vaccine|May 11, 2005
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Kathleen M Neuzil, Cynthia G Whitney, et al.
The New England Journal of Medicine|May 2, 2003
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccineCynthia G Whitney, Monica M Farley, James Hadler, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adultsDaniel R Feikin, Cheryl M Elie, Matthew B Goetz, et al.
BMC Public Health|December 9, 2016
Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introductionShampa Saha, Md Hasan, Lindsay Kim, et al.
Cell Reports|January 18, 2016
T Cell Help Amplifies Innate Signals in CD8(+) DCs for Optimal CD8(+) T Cell PrimingMarie Greyer, Paul G Whitney, Angus T Stock, et al.
Vaccine|October 24, 2001
Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adultsD R Feikin, C M Elie, M B Goetz, et al.
Journal of Clinical Microbiology|July 1, 1997
The role of arbitrarily primed PCR in identifying the source of an outbreak of Legionnaires' diseaseC G Whitney, J Hofmann, J M Pruckler, et al.
Vaccine|March 20, 2025
Impact of 10-valent pneumococcal conjugate vaccine on the epidemiology of otitis media with otorrhea among Bangladeshi childrenHakka Naziat, Md Hafizur Rahman, Rajib C Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003Carolyn M Greene, Moe H Kyaw, Susan M Ray, et al.
Pageof 58